Skip to main content

Detection of Mutations Causing Hemophilia A Using an In Vitro Coupled Transcription and Translation System

  • Protocol
  • 520 Accesses

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 31))

Abstract

Mutation detection in the factor VIII gene is complicated by the size and complexity of the gene—186 kb spanning 26 exons. The exons vary in size from 69 bp to 3106 bp and the introns from 207 bp to 32.4 kb (1). The first mutations to be identified in the factor VIII gene involved mutations at Taq I restriction sites (an enzyme that contains the mutational CpG dinucleotide within its recognition sequence) or were large deletions detected by Southern blotting (2). Small deletions, substitution, and missense mutations proved more difficult to detect as these appear to be randomly distributed throughout the factor VIII gene. For these reasons, therefore, many laboratories involved in carrier detection in Hemophilia A have used an indirect procedure known as gene tracking or linkage analysis. This involves the use of various polymorphic markers (RFLPs and VNTRs) to follow the segregation of the defective factor VIII gene through individuals in a family (This is not covered in this chapter, but an excellent review on the subject is available [3]). Several factors limit this technique, primarily the need for intervening family members, the need for a proband to be present, the occasional need for paternity testing, and the frequent occasions where all polymorphic markers prove to be uninformative. Furthermore, it adds little to our understanding of the mutations that underlie Hemophilia A.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Green, P. M, et al. (1991) Genetics and molecular biology of haemophilia A & B. Blood Coag. Fibrinol. 2, 539–565.

    Article  CAS  Google Scholar 

  2. Tuddenham, E. G. D. (1993) Flipping the tip of the X. Nat. Genetics 5, 209.

    Article  CAS  Google Scholar 

  3. Peake, I. R., et al. (1993) Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coag. Fibrinol. 4, 313–344.

    Article  CAS  Google Scholar 

  4. Gardner, R. J., et al. (1995) The identification of point mutation in Duchenne muscular dystrophy patients by using reverse transcription PCR and the protein truncation test. Am. J. Human Genetics 57, 311–320.

    CAS  Google Scholar 

  5. Tuffery, S., et al. (1996) Four novel dystrophin point mutations: detection by protein truncation test and transcript analysis in lymphocytes from Duchenne muscular dystrophy patients. Eur. J. Human Genetics 4, 143–152.

    CAS  Google Scholar 

  6. van Essen, A. J., et al. (1997) The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol. J. Med. Genetics 34, 805–812.

    Article  Google Scholar 

  7. Romey, M. C. (1996) Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction technique and the protein truncation test. Human Genetics 98, 328–332.

    Article  CAS  PubMed  Google Scholar 

  8. Peral, B., et al. (1997) Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am. J. Human Genetics 60, 1399–1410.

    Article  CAS  Google Scholar 

  9. De Benedetti, V. M., et al. (1996) Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test. Oncogene 13, 1353–1357.

    PubMed  Google Scholar 

  10. Heim, R. A., et al. (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Human Mol. Genetics 4, 975–981.

    Article  CAS  Google Scholar 

  11. Naylor, J. A., Green, P. M., Montandon, A. J., Rizza, C. R., Giannelli, F. (1991) Detection of three novel mutations in two haemophilia A patients by rapid screening of whole essential region of factor VIII gene. Lancet 337, 635–639.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Humana Press Inc.

About this protocol

Cite this protocol

Ononye, C., Jenkins, P.V. (1999). Detection of Mutations Causing Hemophilia A Using an In Vitro Coupled Transcription and Translation System. In: Perry, D.J., Pasi, K.J. (eds) Hemostasis and Thrombosis Protocols. Methods in Molecular Medicine™, vol 31. Humana Press. https://doi.org/10.1385/1-59259-248-1:117

Download citation

  • DOI: https://doi.org/10.1385/1-59259-248-1:117

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-419-8

  • Online ISBN: 978-1-59259-248-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics